Cargando…

The adverse impact of coronary artery disease on left ventricle systolic and diastolic function in patients with type 2 diabetes mellitus: a 3.0T CMR study

BACKGROUND: Coronary artery disease (CAD) confers considerable morbidity and mortality in diabetes. However, the role of CAD in additive effect of left ventricular (LV) function has rarely been explored in type 2 diabetes mellitus (T2DM) patients. This study aimed to investigate how CAD affect LV sy...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Jin, Li, Yuan, Guo, Ying-Kun, Huang, Shan, Shi, Rui, Yan, Wei-Feng, Qian, Wen-Lei, He, Guang-Xi, Yang, Zhi-Gang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8864799/
https://www.ncbi.nlm.nih.gov/pubmed/35193565
http://dx.doi.org/10.1186/s12933-022-01467-y
_version_ 1784655525314560000
author Wang, Jin
Li, Yuan
Guo, Ying-Kun
Huang, Shan
Shi, Rui
Yan, Wei-Feng
Qian, Wen-Lei
He, Guang-Xi
Yang, Zhi-Gang
author_facet Wang, Jin
Li, Yuan
Guo, Ying-Kun
Huang, Shan
Shi, Rui
Yan, Wei-Feng
Qian, Wen-Lei
He, Guang-Xi
Yang, Zhi-Gang
author_sort Wang, Jin
collection PubMed
description BACKGROUND: Coronary artery disease (CAD) confers considerable morbidity and mortality in diabetes. However, the role of CAD in additive effect of left ventricular (LV) function has rarely been explored in type 2 diabetes mellitus (T2DM) patients. This study aimed to investigate how CAD affect LV systolic and diastolic function in T2DM patients. MATERIALS AND METHODS: A total of 282 T2DM patients {104 patients with CAD [T2DM (CAD +)] and 178 without [T2DM (CAD −)]} and 83 sex- and age- matched healthy controls underwent cardiac magnetic resonance scanning. LV structure, function, global strains [including systolic peak strain (PS), peak systolic (PSSR) and diastolic strain rate (PDSR) in radial, circumferential and longitudinal directions] and late gadolinium enhancement (LGE) parameters were measured. T2DM (CAD +) patients were divided into two subgroups based on the median of Gensini score (60) which was calculated to assess the severity of CAD. Multivariable linear regression analyses were constructed to investigate the determinants of reduced LV function. RESULTS: Compared with normal controls, T2DM (CAD −) patients exhibited increased LV end-diastolic and end-systolic volume index and decreased LV global strains, while T2DM(CAD +) patients showed more marked increase and decrease than T2DM(CAD-) and healthy controls, except for longitudinal PDSR (PDSR-L) (all P < 0.017). All of LV global strains demonstrated a progressive decrease from normal controls, through Gensini score ≤ 60, to Gensini score > 60 group, except for PDSR-L (all P < 0.017). CAD was an independent predictor of reduced LV global circumferential PS (GCPS, β = 0.22, p < 0.001), PSSR (PSSR-C, β = 0.17, p = 0.005), PDSR (PDSR-C, β = 0.22, p < 0.001), global radial PS (GRPS, β = 0.19, p = 0.001), and global longitudinal PS (GLPS, β = 0.18, p = 0.003) in T2DM. The Gensini score was associated with decreased GCPS, PSSR-C, PDSR-C, GRPS, and GLPS in T2DM (CAD +) (all p < 0.05). CONCLUSION: CAD has an additive deleterious effect on LV systolic and diastolic function in T2DM patients. Among T2DM (CAD +) patients, the Gensini score is associated with reduced LV contractile and diastolic function. Trial registration Retrospectively registered
format Online
Article
Text
id pubmed-8864799
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-88647992022-02-23 The adverse impact of coronary artery disease on left ventricle systolic and diastolic function in patients with type 2 diabetes mellitus: a 3.0T CMR study Wang, Jin Li, Yuan Guo, Ying-Kun Huang, Shan Shi, Rui Yan, Wei-Feng Qian, Wen-Lei He, Guang-Xi Yang, Zhi-Gang Cardiovasc Diabetol Original Investigation BACKGROUND: Coronary artery disease (CAD) confers considerable morbidity and mortality in diabetes. However, the role of CAD in additive effect of left ventricular (LV) function has rarely been explored in type 2 diabetes mellitus (T2DM) patients. This study aimed to investigate how CAD affect LV systolic and diastolic function in T2DM patients. MATERIALS AND METHODS: A total of 282 T2DM patients {104 patients with CAD [T2DM (CAD +)] and 178 without [T2DM (CAD −)]} and 83 sex- and age- matched healthy controls underwent cardiac magnetic resonance scanning. LV structure, function, global strains [including systolic peak strain (PS), peak systolic (PSSR) and diastolic strain rate (PDSR) in radial, circumferential and longitudinal directions] and late gadolinium enhancement (LGE) parameters were measured. T2DM (CAD +) patients were divided into two subgroups based on the median of Gensini score (60) which was calculated to assess the severity of CAD. Multivariable linear regression analyses were constructed to investigate the determinants of reduced LV function. RESULTS: Compared with normal controls, T2DM (CAD −) patients exhibited increased LV end-diastolic and end-systolic volume index and decreased LV global strains, while T2DM(CAD +) patients showed more marked increase and decrease than T2DM(CAD-) and healthy controls, except for longitudinal PDSR (PDSR-L) (all P < 0.017). All of LV global strains demonstrated a progressive decrease from normal controls, through Gensini score ≤ 60, to Gensini score > 60 group, except for PDSR-L (all P < 0.017). CAD was an independent predictor of reduced LV global circumferential PS (GCPS, β = 0.22, p < 0.001), PSSR (PSSR-C, β = 0.17, p = 0.005), PDSR (PDSR-C, β = 0.22, p < 0.001), global radial PS (GRPS, β = 0.19, p = 0.001), and global longitudinal PS (GLPS, β = 0.18, p = 0.003) in T2DM. The Gensini score was associated with decreased GCPS, PSSR-C, PDSR-C, GRPS, and GLPS in T2DM (CAD +) (all p < 0.05). CONCLUSION: CAD has an additive deleterious effect on LV systolic and diastolic function in T2DM patients. Among T2DM (CAD +) patients, the Gensini score is associated with reduced LV contractile and diastolic function. Trial registration Retrospectively registered BioMed Central 2022-02-22 /pmc/articles/PMC8864799/ /pubmed/35193565 http://dx.doi.org/10.1186/s12933-022-01467-y Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Original Investigation
Wang, Jin
Li, Yuan
Guo, Ying-Kun
Huang, Shan
Shi, Rui
Yan, Wei-Feng
Qian, Wen-Lei
He, Guang-Xi
Yang, Zhi-Gang
The adverse impact of coronary artery disease on left ventricle systolic and diastolic function in patients with type 2 diabetes mellitus: a 3.0T CMR study
title The adverse impact of coronary artery disease on left ventricle systolic and diastolic function in patients with type 2 diabetes mellitus: a 3.0T CMR study
title_full The adverse impact of coronary artery disease on left ventricle systolic and diastolic function in patients with type 2 diabetes mellitus: a 3.0T CMR study
title_fullStr The adverse impact of coronary artery disease on left ventricle systolic and diastolic function in patients with type 2 diabetes mellitus: a 3.0T CMR study
title_full_unstemmed The adverse impact of coronary artery disease on left ventricle systolic and diastolic function in patients with type 2 diabetes mellitus: a 3.0T CMR study
title_short The adverse impact of coronary artery disease on left ventricle systolic and diastolic function in patients with type 2 diabetes mellitus: a 3.0T CMR study
title_sort adverse impact of coronary artery disease on left ventricle systolic and diastolic function in patients with type 2 diabetes mellitus: a 3.0t cmr study
topic Original Investigation
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8864799/
https://www.ncbi.nlm.nih.gov/pubmed/35193565
http://dx.doi.org/10.1186/s12933-022-01467-y
work_keys_str_mv AT wangjin theadverseimpactofcoronaryarterydiseaseonleftventriclesystolicanddiastolicfunctioninpatientswithtype2diabetesmellitusa30tcmrstudy
AT liyuan theadverseimpactofcoronaryarterydiseaseonleftventriclesystolicanddiastolicfunctioninpatientswithtype2diabetesmellitusa30tcmrstudy
AT guoyingkun theadverseimpactofcoronaryarterydiseaseonleftventriclesystolicanddiastolicfunctioninpatientswithtype2diabetesmellitusa30tcmrstudy
AT huangshan theadverseimpactofcoronaryarterydiseaseonleftventriclesystolicanddiastolicfunctioninpatientswithtype2diabetesmellitusa30tcmrstudy
AT shirui theadverseimpactofcoronaryarterydiseaseonleftventriclesystolicanddiastolicfunctioninpatientswithtype2diabetesmellitusa30tcmrstudy
AT yanweifeng theadverseimpactofcoronaryarterydiseaseonleftventriclesystolicanddiastolicfunctioninpatientswithtype2diabetesmellitusa30tcmrstudy
AT qianwenlei theadverseimpactofcoronaryarterydiseaseonleftventriclesystolicanddiastolicfunctioninpatientswithtype2diabetesmellitusa30tcmrstudy
AT heguangxi theadverseimpactofcoronaryarterydiseaseonleftventriclesystolicanddiastolicfunctioninpatientswithtype2diabetesmellitusa30tcmrstudy
AT yangzhigang theadverseimpactofcoronaryarterydiseaseonleftventriclesystolicanddiastolicfunctioninpatientswithtype2diabetesmellitusa30tcmrstudy
AT wangjin adverseimpactofcoronaryarterydiseaseonleftventriclesystolicanddiastolicfunctioninpatientswithtype2diabetesmellitusa30tcmrstudy
AT liyuan adverseimpactofcoronaryarterydiseaseonleftventriclesystolicanddiastolicfunctioninpatientswithtype2diabetesmellitusa30tcmrstudy
AT guoyingkun adverseimpactofcoronaryarterydiseaseonleftventriclesystolicanddiastolicfunctioninpatientswithtype2diabetesmellitusa30tcmrstudy
AT huangshan adverseimpactofcoronaryarterydiseaseonleftventriclesystolicanddiastolicfunctioninpatientswithtype2diabetesmellitusa30tcmrstudy
AT shirui adverseimpactofcoronaryarterydiseaseonleftventriclesystolicanddiastolicfunctioninpatientswithtype2diabetesmellitusa30tcmrstudy
AT yanweifeng adverseimpactofcoronaryarterydiseaseonleftventriclesystolicanddiastolicfunctioninpatientswithtype2diabetesmellitusa30tcmrstudy
AT qianwenlei adverseimpactofcoronaryarterydiseaseonleftventriclesystolicanddiastolicfunctioninpatientswithtype2diabetesmellitusa30tcmrstudy
AT heguangxi adverseimpactofcoronaryarterydiseaseonleftventriclesystolicanddiastolicfunctioninpatientswithtype2diabetesmellitusa30tcmrstudy
AT yangzhigang adverseimpactofcoronaryarterydiseaseonleftventriclesystolicanddiastolicfunctioninpatientswithtype2diabetesmellitusa30tcmrstudy